New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A4548

Introduced
3/10/26  

Caption

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

Impact

The implications of this bill are significant for statewide health and safety regulations within educational institutions. By requiring schools to stock glucagon and allowing authorized personnel to administer it, the bill enhances the safety of students diagnosed with diabetes. Given that severe hypoglycemia can pose immediate danger, having ready access to glucagon therapy within schools can save lives and prevent adverse outcomes. Furthermore, this legislation integrates preventive health measures into everyday school operations, fostering a more supportive environment for students with chronic health conditions.

Summary

Assembly Bill A4548 is a legislative measure that concerns the administration of ready-to-use undesignated glucagon rescue therapy in public schools in New Jersey. The bill mandates that each school district obtains a standing order for ready-to-use glucagon treatment, emphasizing the codependency between emergency intervention and rigorous adherence to established protocols. The bill seeks to ensure that school employees are sufficiently equipped and authorized to administer glucagon to students suspected of experiencing severe hypoglycemic reactions, a critical condition for students with diabetes that can lead to serious health complications if not addressed promptly.

Contention

While the bill is largely supportive and has been created to improve the welfare of students with diabetes, there may be concerns regarding the training and readiness of school employees to administer medical treatments. Questions may arise around the adequacy of training protocols, potential liabilities for school personnel, and the overall effectiveness of emergency plans tailored for individual students. These factors might lead to discussions on the adequacy of resources provided by school districts to support the effective implementation of this bill and may require ongoing evaluation and oversight to ensure that the intentions of the legislation are fulfilled.

Companion Bills

No companion bills found.

Similar Bills

KY HB75

AN ACT relating to undesignated glucagon.

KY HB174

AN ACT relating to undesignated glucagon.

KY HB263

AN ACT relating to undesignated glucagon.

MA H671

Relative to undesignated glucagon rescue therapies in schools

FL H0597

Diabetes Management in Schools

FL S0772

Diabetes Management in Schools

KY HB688

AN ACT relating to health care.